9 research outputs found
Why do women want to be beautiful? A qualitative study proposing a new “human beauty values” concept
<div><p>This study investigated the underlying reasons women desire to be beautiful in South Korean, Chinese, and Japanese cultures by proposing a new concept called human beauty value (HBV). This exploratory qualitative study includes a literature review in related disciplines and the results from ten focus group interviews. Based on the interviews, this study proposes four dimensions of HBV (i.e., superiority, self-development, individuality, and authenticity) and a hierarchical process among the antecedents (i.e., social comparison, social competition, and social norms), the pursuit of HBV, and the consequences (i.e., emotional, attitudinal, and behavioral aspects). Participants from each culture revealed a unique hierarchical process of HBV that reflects both cultural universality and specificity. The results of this study lead to new knowledge about East Asian women’s identities and perceptions of beauty. In addition, the proposed concept, HBV, can broaden the academic lens for beauty-related disciplines.</p></div
Qualitative construct, category, and frequency.
<p>Qualitative construct, category, and frequency.</p
Information on the stimuli of cultural beauty and personal beauty.
<p>Information on the stimuli of cultural beauty and personal beauty.</p
Structural framework and dimensions of HBV.
<p>Structural framework and dimensions of HBV.</p
Synthesis, Characterization, and Reactivity of a Highly Oxidative Mononuclear Manganese(IV)–Bis(Fluoro) Complex
Recently, transition-metal terminal
nonoxo complexes have shown
a remarkable ability to activate and functionalize C–H bonds
via proton-coupled electron transfer (PCET). Here we report the first
example of a mononuclear manganese(IV) bis(fluoro) complex bearing
a tetradentate pyridinophane ligand, [MnIV(TBDAP)(F)2]2+ (3), with an X-ray single crystal
structure and physicochemical characterization. The manganese(IV)
bis(fluoro) complex has a very high reduction potential of 1.61 V
vs SCE, thereby enabling the four-electron oxidation of mesitylene
to 3,5-dimethylbenzaldehyde. Kinetic studies, including the kinetic
isotope effect and employment of other toluene derivatives, reveal
the electron transfer (ET)-driven PCET in the C–H bond activation
of mesitylene by 3. This novel metal halide intermediate
would be prominently valuable for expanding transition-metal halide
chemistry
Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α‑Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability
Cell-penetrating
peptides (CPPs) often have cationic and amphipathic
characteristics that are commonly associated with α-helical
peptides. These features give CPPs both membrane demolishing and penetrating
abilities. To make CPPs safe for biomedical applications, their toxicities
resulting from their membrane demolishing abilities must be removed
while their cell penetrating abilities must be retained. In this study,
we systematically constructed mutants of the amphipathic α-helical
model peptide (LKKÂLÂLÂKÂLÂLÂKÂKÂLÂLÂKÂLAG,
LK peptide). The hydrophobic amino acid leucine in the LK peptide
was replaced with hydrophilic amino acids to reduce hemolytic or cell
toxicity. Most of the mutants were found to have weakened membrane
disrupting abilities, but their cell penetrating abilities were also
weakened. However, the L8Q and L8K mutants were found to have low
micromolar range cell penetrating ability and almost no membrane disrupting
ability. These selected mutants utilize energy-dependent endocytosis
mechanisms instead of an energy-independent direct cell penetrating
mechanism to enter cells. In addition, the mutants can be used to
deliver the anticancer drug methotrexate (MTX) to cells, thereby overcoming
resistance to this drug. To determine if the effect of these mutations
on the membrane disrupting and cell penetrating abilities is general,
Q and K mutations of the natural amphipathic α-helical antimicrobial
peptide (AMP), LL37, were introduced. Specific positional Q and K
mutants of LL37 were found to have lower hemolytic toxicities and
preserved the ability to penetrate eukaryotic cells such as MDA-MB-231
cells. Taken together, observations made in this work suggest that
interrupting the global hydrophobicity of amphipathic α-helical
CPPs and AMPs, by replacing hydrophobic residues with mildly hydrophilic
amino acids such as Q and K, might be an ideal strategy for constructing
peptides that have strong cell penetrating abilities and weak cell
membrane disrupting abilities
Isolation, Synthesis, and Antisepsis Effects of a <i>C</i>‑Methylcoumarinochromone Isolated from <i>Abronia nana</i> Cell Culture
Only a few isoflavones have been
isolated from plants of the genus <i>Abronia</i>. The biological
properties of compounds isolated
from <i>Abronia</i> species have not been well established,
and their antisepsis effects have not been reported yet. In the present
study, a new <i>C</i>-methylcoumarinochromone, was isolated
from <i>Abronia nana</i> suspension cultures. Its structure
was deduced as 9,11-dihydroxy-10-methylcoumarinochromone (boeravinone
Y, <b>1</b>) by spectroscopic data analysis and verified by
chemical synthesis. The potential inhibitory effects of <b>1</b> against high mobility group box 1 (HMGB1)-mediated septic responses
were investigated. Results showed that <b>1</b> effectively
inhibited lipopolysaccharide-induced release of HMGB1 and suppressed
HMGB1-mediated septic responses, in terms of reduction of hyperpermeability,
leukocyte adhesion and migration, and cell adhesion molecule expression.
In addition, <b>1</b> increased the phagocytic activity of macrophages
and exhibited bacterial clearance effects in the peritoneal fluid
and blood of mice with cecal ligation and puncture-induced sepsis.
Collectively, these results suggested that <b>1</b> might have
potential therapeutic activity against various severe vascular inflammatory
diseases <i>via</i> inhibition of the HMGB1 signaling pathway